Zacks Investment Research on MSN
Is it the right time to add Insulet stock to your portfolio?
Insulet PODD is well-poised to grow in the coming quarters due to the strength of its Omnipod 5 platform. The company is strongly executing against its long-term priorities to drive penetration, ...
I got an exclusive hands-on demo of the latest humanoid robot from LimX Dynamics, Oli, and put it through its paces with an epic dance battle.
The race to release world models is on as AI image and video generation company Runway joins an increasing number of startups and Big Tech companies by launching its first one. Dubbed GWM-1, the model ...
Shares of DexCom Inc. DXCM shed 1.84% to $65.73 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.16% to 6,816.51 and Dow ...
Hosted on MSN
Morgan Stanley upgrades DexCom (DXCM), cites undervalued recovery and G7 margin potential
DexCom Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy in 2026. On December 2, Morgan Stanley upgraded DexCom to Overweight from Equal Weight with a price target of $75, which was up from ...
The Baltimore Ravens take on the Pittsburgh Steelers on Sunday Night Football during Week 18 of the 2025 NFL season. Here's everything you need to know when the Washington Commanders play the ...
As the year comes to a close, it's time to look back at the numerous innovations across the diabetes technology industry in ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results